Box 2-HairLossProd
Container
Contains 13 Results:
"A Clinical Trial of Foltene" by Dr. Hincky
File — Box: 2-HairLossProd, Folder: 1
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
1887-2001
Foltene Communications Study
File — Box: 2-HairLossProd, Folder: 2
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
1887-2001
Foltene Correspondence, January-June 1987
File — Box: 2-HairLossProd, Folder: 3
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
January-June 1987
Foltene Correspondence, July-December 1987
File — Box: 2-HairLossProd, Folder: 4
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
July-December 1987
Hair Loss Products Advertisements
File — Box: 2-HairLossProd, Folder: 5
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
1887-2001
Hair Loss Products Articles
File — Box: 2-HairLossProd, Folder: 6
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
1887-2001
Hair Loss Products Information
File — Box: 2-HairLossProd, Folder: 7
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
1887-2001
Hair Loss Products Memorandum and Legal Recommendations, 1987
File — Box: 2-HairLossProd, Folder: 8
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
1987
Hair Loss Products Memorandum and Legal Recommendations, first draft, 1987
File — Box: 2-HairLossProd, Folder: 9
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
1987
Headstart Hair Care
File — Box: 2-HairLossProd, Folder: 10
Scope and Contents
From the Series:
Material in this series relates to the injunctions brought against hair growth product and clinics by Upjohn for deceptive practices. This was done because Upjohn was working on a product (Rogaine) that was scientifically proven to treat male pattern baldness and did not want to face competition that did not hold to these standards. Most of the material is prior to August 1988 when Rogaine was approved by the FDA and includes legal memoranda, motions, petitions, correspondence, as well as...
Dates:
1887-2001